🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Meningococcal Infections

National Bacterial Meningitis Study in Children and Newborns NCT04664569n/a1 site📍 Créteil Association Clinique Thérapeutique Infantile du val de Marne Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US) NCT04843111n/a1 site📍 Swiftwater Sanofi Pasteur, a Sanofi Company · Tests: Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China NCT07710872Phase 38 sites📍 Huanggang📍 Jianli City, Jingzhou City📍 Jingxi Sanofi · Tests: MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur … Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine NCT07203755Phase 11 site📍 Shangqiu CanSino Biologics Inc. · Tests: Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Menin… Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug NCT06834100Phase 317 sites📍 Kirov📍 Moscow📍 Moscow NPO Petrovax · Tests: polysaccharide conjugated vaccine for prevention of meningococcal infection of serogroups A, C, W, Y Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old NCT07204457Phase 2, Phase 31 site📍 Seoul EyeGene Inc. · Tests: EG-MCV4, Menveo Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months NCT07505836Phase 32 sites📍 Nanning📍 Taiyuan Sinovac Biotech Co., Ltd · Tests: experimental vaccine, Active Comparator vaccine Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months NCT07505823Phase 32 sites📍 Nanning📍 Taiyuan Sinovac Biotech Co., Ltd · Tests: experimental vaccine, Active Comparator vaccine Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV NCT04875819Phase 41 site📍 Hvidovre Thomas Benfield · Tests: Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine, 13 valent pneumococcal … Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months NCT07505810Phase 32 sites📍 Nanning📍 Taiyuan Sinovac Biotech Co., Ltd · Tests: experimental vaccine, Active Comparator vaccine Meningococcal B Vaccine in Patients with Asplenia NCT06025487Phase 21 site📍 Vienna Medical University of Vienna · Tests: Bexsero Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons NCT06832514Phase 41 site📍 Ghent University Ghent · Tests: Serogroup B meningococal vaccine A Study to Learn About the Safety of PENBRAYA During Pregnancy NCT07768163n/a1 site📍 New York Pfizer · Tests: PENBRAYA
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy